Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D1MK7G
|
|||
| Drug Name |
AR-501
|
|||
| Synonyms |
Gallium citrate; 27905-02-8; UNII-HT6C49L0ZP; Citric acid, gallium(II) salt; HT6C49L0ZP; CITRIC ACID, GALLIUM SALT (1:1); gallium;2-hydroxypropane-1,2,3-tricarboxylate; 30403-03-3; EINECS 248-721-1; NSC 15011; gallium 2-hydroxypropane-1,2,3-tricarboxylate; SCHEMBL37799; DTXSID50952742; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, gallium salt
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cystic fibrosis [ICD-11: CA25; ICD-10: E84, E84.9] | Phase 1/2 | [1] | |
| Company |
Aridis Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C6H5GaO7
|
|||
| Canonical SMILES |
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Ga+3]
|
|||
| InChI |
1S/C6H8O7.Ga/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3
|
|||
| InChIKey |
YEEGWNXDUZONAA-UHFFFAOYSA-K
|
|||
| CAS Number |
CAS 27905-02-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03669614) SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.